Frank Rimerman Advisors’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.59M Buy
16,802
+13
+0.1% +$2.91K 0.24% 73
2025
Q4
$2.87M Buy
16,789
+86
+0.5% +$13.4K 0.18% 92
2025
Q3
$2.24M Buy
16,703
+1,144
+7% +$121K 0.14% 112
2025
Q2
$1.51M Sell
15,559
-18,181
-54% -$1.44M 0.1% 150
2025
Q1
$2.45M Buy
33,740
+18,681
+124% +$1.47M 0.19% 87
2024
Q4
$1.09M Sell
15,059
-1,081
-7% -$82K 0.08% 187
2024
Q3
$1.32M Sell
16,140
-12,980
-45% -$1.13M 0.09% 174
2024
Q2
$3.1M Buy
29,120
+29,040
+36,300% +$2.79M 0.22% 73
2024
Q1
$7.77K Hold
80
﹤0.01% 186
2023
Q4
$6.27K Buy
+80
New +$5.45K ﹤0.01% 189
2022
Q2
Sell
-13,110
Closed -$705K 108
2022
Q1
$705K Hold
13,110
0.23% 60
2021
Q4
$943K Buy
13,110
+5,140
+64% +$322K 0.32% 47
2021
Q3
$454K Buy
+7,970
New +$485K 0.18% 68

Other funds holding LRCX

Frank Rimerman Advisors's LRCX Position: Q1 2026 in Review

Frank Rimerman Advisors increased its Lam Research (LRCX) stake by 0.08% in Q1 2026, buying an estimated $2.91K and bringing the position to 16,802 shares worth $3.59M. The position accounts for 0.24% of the portfolio, ranked #73.

Frank Rimerman Advisors first reported a position in LRCX in Q3 2021 and has held it in 13 quarters since. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

  • Frank Rimerman Advisors held 16,802 shares of Lam Research worth $3.59M as of Q1 2026.
  • Frank Rimerman Advisors bought 13 Lam Research shares in Q1 2026, an estimated $2.91K.
  • Lam Research made up 0.24% of Frank Rimerman Advisors's portfolio in Q1 2026, its #73 holding.
  • Frank Rimerman Advisors first reported a position in Lam Research in Q3 2021 and has held it in 13 quarters since.
  • 2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Frank Rimerman Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.